BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23417963)

  • 1. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
    Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
    Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis.
    Graver JC; Jiemy WF; Altulea DHA; van Sleen Y; Xu S; van der Geest KSM; Verstappen GMPJ; Heeringa P; Abdulahad WH; Brouwer E; Boots AMH; Sandovici M
    J Autoimmun; 2023 Nov; 140():103111. PubMed ID: 37703805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired IL-6-induced JAK-STAT signaling in CD4
    Esen I; Sandovici M; Heeringa P; Boots AMH; Brouwer E; van Sleen Y; Abdulahad W
    J Autoimmun; 2024 Jun; 146():103215. PubMed ID: 38653164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced immune effector cell NKG2D expression and increased levels of soluble NKG2D ligands in multiple myeloma may not be causally linked.
    von Lilienfeld-Toal M; Frank S; Leyendecker C; Feyler S; Jarmin S; Morgan R; Glasmacher A; Märten A; Schmidt-Wolf IG; Brossart P; Cook G
    Cancer Immunol Immunother; 2010 Jun; 59(6):829-39. PubMed ID: 20024547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.
    Zloza A; Kohlhapp FJ; Lyons GE; Schenkel JM; Moore TV; Lacek AT; O'Sullivan JA; Varanasi V; Williams JW; Jagoda MC; Bellavance EC; Marzo AL; Thomas PG; Zafirova B; Polić B; Al-Harthi L; Sperling AI; Guevara-Patiño JA
    Nat Med; 2012 Feb; 18(3):422-8. PubMed ID: 22366950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senescent cells in giant cell arteritis display an inflammatory phenotype participating in tissue injury via IL-6-dependent pathways.
    Veroutis D; Argyropoulou OD; Goules AV; Kambas K; Palamidas DA; Evangelou K; Havaki S; Polyzou A; Valakos D; Xingi E; Karatza E; Boki KA; Cavazza A; Kittas C; Thanos D; Ricordi C; Marvisi C; Muratore F; Galli E; Croci S; Salvarani C; Gorgoulis VG; Tzioufas AG
    Ann Rheum Dis; 2024 Feb; 83(3):342-350. PubMed ID: 38050005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between infection and the onset of giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis.
    Pacoureau L; Barde F; Seror R; Nguyen Y
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37949615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica.
    Dejaco C; Kerschbaumer A; Aletaha D; Bond M; Hysa E; Camellino D; Ehlers L; Abril A; Appenzeller S; Cid MC; Dasgupta B; Duftner C; Grayson PC; Hellmich B; Hočevar A; Kermani TA; Matteson EL; Mollan SP; Neill L; Ponte C; Salvarani C; Sattui SE; Schmidt WA; Seo P; Smolen JS; Thiel J; Toro-Gutiérrez CE; Whitlock M; Buttgereit F
    Ann Rheum Dis; 2024 Jan; 83(1):48-57. PubMed ID: 36828585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of phase 2/3 trials in polymyalgia rheumatica and giant cell arteritis.
    Nageswaran P; Ahmed S; Tahir H
    Expert Opin Emerg Drugs; 2024 Mar; 29(1):5-17. PubMed ID: 38180809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant Polymyalgia Rheumatica and Giant Cell Arteritis Associated with Cystic Echinococcosis: A Rare Geriatric Case.
    Bektan Kanat B; Ulugerger Avci G; Icli TB; Doventas A
    Acta Parasitol; 2024 Mar; 69(1):1085-1089. PubMed ID: 38451439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common co-morbidities in polymyalgia rheumatica and giant cell arteritis: cross-sectional study in UK Biobank.
    Chatzigeorgiou C; Taylor JC; Elliott F; O'Sullivan EP; Morgan AW; Barrett JH; Mackie SL
    Rheumatol Adv Pract; 2023; 7(3):rkad095. PubMed ID: 38033363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding CD4
    Estupiñán-Moreno E; Hernández-Rodríguez J; Li T; Ciudad L; Andrés-León E; Terron-Camero LC; Prieto-González S; Espígol-Frigolé G; Cid MC; Márquez A; Martin J; Ballestar E; Ortiz-Fernández L
    J Autoimmun; 2024 Jun; 146():103240. PubMed ID: 38754238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors.
    Maccalli C; Scaramuzza S; Parmiani G
    Cancer Immunol Immunother; 2009 May; 58(5):801-8. PubMed ID: 19089424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    Manning JE; Harris E; Mathieson H; Sorensen L; Luqmani R; McGettrick HM; Morgan AW; Young SP; Mackie SL
    J Autoimmun; 2024 May; 147():103260. PubMed ID: 38797046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis.
    Xu S; Jiemy WF; Boots AMH; Arends S; van Sleen Y; Nienhuis PH; van der Geest KSM; Heeringa P; Brouwer E; Sandovici M
    Arthritis Care Res (Hoboken); 2024 Apr; ():. PubMed ID: 38685696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
    Greigert H; Ramon A; Genet C; Cladière C; Gerard C; Cuidad M; Corbera-Bellalta M; Alba-Rovira R; Arnould L; Creuzot-Garcher C; Martin L; Tarris G; Ghesquière T; Ouandji S; Audia S; Cid MC; Bonnotte B; Samson M
    J Autoimmun; 2024 Jan; 142():103151. PubMed ID: 38039746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contributions of deleterious rare alleles in NLRP12 and inflammasome-related genes to polymyalgia rheumatica.
    Higuchi T; Oka S; Furukawa H; Tohma S
    Sci Rep; 2024 Jan; 14(1):490. PubMed ID: 38177227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musculoskeletal magnetic resonance imaging findings support a common spectrum of giant cell arteritis and polymyalgia rheumatica.
    Seitz P; Cullmann J; Bucher S; Bütikofer L; Reichenbach S; Lötscher F; Amsler J; Christ L; Bonel HM; Villiger PM; Seitz L
    Rheumatology (Oxford); 2024 Jan; ():. PubMed ID: 38265241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, Serological, and Immunological Characteristics of Greek Patients with Polymyalgia Rheumatica and/or Giant Cell Arteritis: A Research Protocol.
    Memi T; Koletsos N; Gerolymatou N; Karakosta M; Georgiadis AN; Drosos AA; Voulgari PV
    Mediterr J Rheumatol; 2023 Dec; 34(4):577-580. PubMed ID: 38282939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominance of T-bet-positive Th1 cells in infiltrating T-lymphocytes in most of active arteritis lesions of giant cell arteritis.
    Satomi H; Kobayashi M; Ito I; Asano K; Makino M; Kawaguchi K; Kanno H
    Virchows Arch; 2024 Mar; ():. PubMed ID: 38478104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.